FLASH NEWS LIVE

Sun to Soar Globally with Organon

Sun to Soar Globally with Organon

Dilip Shanghvi-led Sun Pharma has agreed to acquire US-based drug maker Organon for $11.75 billion in an all-cash deal. Sun will pay $14 per share, a premium of roughly 24% for the NYSE-listed company.

Read Full Article →

Read more

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.
Instagram Meta X LinkedIn Whatsapp